OptimizeRx Corp Annual Weighted Average Number of Shares Outstanding, Diluted from 2013 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
OptimizeRx Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2013 to 2023.
  • OptimizeRx Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 18.3M shares, a 10.1% increase year-over-year.
  • OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 17.1M shares, a 3.71% decline from 2022.
  • OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17.8M shares, a 0.53% increase from 2021.
  • OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 17.7M shares, a 19.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 17.1M -659K -3.71% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 17.8M +93.5K +0.53% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 17.7M +2.86M +19.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 14.8M +1.44M +10.8% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
2019 13.4M +1.52M +12.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 11.9M +2.04M +20.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 9.82M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2014 24M +2.81M +13.3% Jan 1, 2014 Dec 31, 2014 10-K/A 2015-09-16
2013 21.2M Jan 1, 2013 Dec 31, 2013 10-K/A 2015-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.